CCL2 and rheumatoid arthritis: Because chronic inflammatory diseases such as MS and RA in which T cell contact is likely to play a pathogenic part are mediated by Th1 and Th17, the production of CCL2 by monocytes/macrophages might be considered as an attempt to revert T cell polarization to a less inflammatory phenotype [39].